hrp0082p2-d1-512 | Pituitary | ESPE2014

Clinical Phenotype and Complications, Endocrinopathies and Neuroimaging Findings in a Case Series of Sod

Maris I , Howard C , Bogue C , Morrissey R , Gregory L C , O'Connell S M , Dattani M T , O'Riordan S M P

Background: Septo-optic dysplasia (SOD) is a highly heterogeneous condition with a variable phenotype, defined as two or more features of the classical triad: i) optic nerve hypoplasia, ii) midline brain defects, and iii) pituitary hormone abnormalities.Objective and hypotheses: To describe the clinical, endocrine, and neuroimaging features in eight children with SOD.Method: Eight (six males) consecutive patients, diagnosed with SO...

hrp0084p3-780 | DSD | ESPE2015

Clinical Findings, Endocrine Profile and Genetic Features of 5α-Reductase-2 Deficiency

Russo Gianni , Baldinotti Fulvia , Ghirri Paolo , Meroni Silvia , Colombo Ilaria , Moscuzza Francesca , Baroncelli Giampiero I , Sessa Maria R , Dati Eleonora , Bertelloni Silvano

Background: The 5α-reductase-2 (5R2) deficiency is a rare 46, XY disorder of sex differentiation caused by mutations in the 5R2 gene. Diagnostic and clinical management is not well definite.Aims and objectives: To describe relevant features of 5R2 deficiency in a large sample.Methods: Retrospective records of persons with 5R2 deficiency were reviewed and clinical, endocrinological, genetic data analysed....

hrp0094p1-115 | Fat, Metabolism and Obesity B | ESPE2021

Circulating C1q Complement/TNF-Related Protein (CTRP)-13 Levels in Obese Children and Its Relationship with Metabolic Disorders

Mert Erbaş Ibrahim , Paketci Ahu , Turan Serkan , Şişman Ali Rıza , Demir Korcan , Bober Ece , Abacı Ayhan ,

Background: C1q/tumor necrosis factor-related proteins (CTRPs) are the recently recognized members of the adipokine family, secreted from adipose tissue. Some types of CTRPs, including CTRP-13, play an important role in energy metabolism in humans. Also, CTRP-13 was found as an anorexigenic factor in experimental studies.Objective: We aimed to investigate serum CTRP-13 levels in obese and healthy children, as well as the...

hrp0094p2-134 | Diabetes and insulin | ESPE2021

Does SARS-COV-2 outbreak increase diabetic ketoacidosis in new onset T1DM

Jalilova Arzu , Ata Gunay Demir Aysun , Işıklar Hafize , Atik Altınok Yasemin , Ozen Samim , Darcan Şukran , Gokşen Damla ,

Introduction: Diabetic ketoacidosis (DKA) is a life-threatening acute complication of type 1 diabetes mellitus (T1DM) and infection is the most common precipitating factor for DKA and is responsible for more than 50% of cases.Aim: We evaluated the frequency and severity of DKA in children with T1DM, before and during the coronavirus disease 2019 (COVID-19) outbreak, in order to identify its indirect effects on DKA incide...

hrp0097p1-78 | Fat, Metabolism and Obesity | ESPE2023

Evaluation of Τri-Ponderal Mass Index as a reflector of adiposity among pediatric cancer survivors

P Kotanidou Eleni , Rengina Tsinopoulou Vasiliki , Giza Styliani , I Sakellari Eleni , Douma Stergianna , Antari Vasiliki , Palampougiouki Maria , Ioannidou Maria , Tragiannidis Athanasios , Hatzipantelis Emmanouil , Galli-Tsinopoulou Assimina

Objectives: Modern treatments lead to increased survival rates from childhood cancer. Childhood cancer survivors (CCS) are a growing population group, which is at high risk for cardiometabolic disorders including metabolic syndrome, type 2 diabetes and cardiovascular disease. Obesity is one of the major drivers of these adverse outcomes, resulted from corticosteroids, radiotherapy, sedentary behavior, and precancer obesity. Assessment of obesity could identify...

hrp0097p1-140 | Multisystem Endocrine Disorders | ESPE2023

Childhood cancer survivors endocrine late effects: one year retrospective observational study

P Kotanidou Eleni , Rengina Tsinopoulou Vasiliki , Giza Styliani , I Sakellari Eleni , Douma Stergianna , Antari Vasiliki , Palampougiouki Maria , Ioannidou Maria , Tragiannidis Athanasios , Hatzipantelis Emmanouil , Galli-Tsinopoulou Assimina

Objectives: Childhood cancer survivors (CCS) are a growing population group. Current oncology treatments have led to improved patient survival rates and an increase in late effects of treatment. Endocrine disturbances, such as pituitary insufficiency, thyroid dysfunction and obesity are the most common late endocrine effects of oncology treatments. The purpose of the study was to investigate the endocrine health of CCS and to record the prevalence of late endo...

hrp0098p2-232 | Pituitary, Neuroendocrinology and Puberty | ESPE2024

A Rare Cause of Ovarian Failure: Transaldolase Deficiency

Alan Tehçi Başak , Doger Esra , Çilesiz Kübra , Tümer Leyla , Kayhan Gulsum , Orhun Çamurdan Mahmut , Bideci Aysun

Purpose: Transaldolase deficiency is a rare, multisystemic, autosomal recessive disease of carbohydrate metabolism characterized clinically by IUGR, bicytopenia (70%), congenital heart diseases (60%), dysmorphic features (50%), liver failure, hepatosplenomegaly, nephrolithiasis and endocrine disorders (30%).Case: A 15-year-5-month-old girl patient was admitted with primary amenorrhea. It was learned that the patient, who...

hrp0098p3-139 | GH and IGFs | ESPE2024

Growth Hormone Therapy in Congenital Tufting Enteropathy: A Case Report and Literature Review

Ali Oktay Mehmet , Orhun Çamurdan Mahmut , Eğritaş Gürkan Ödül , Alan Tehçi Başak , Döğer Esra , Bideci Aysun

Introduction: Congenital tufting enteropathy (CTE) is a rare autosomal recessive enteropathy that typically presents in early life and is often characterized by persistent diarrhea. Height standard deviation scores (SDS) and body mass indexes are generally low in patients with CTE. However, information about the effects of growth hormone (GH) therapy in these patients is lacking.Case Presentation: A 13-year-old girl with...

hrp0094p2-309 | Growth and syndromes (to include Turner syndrome) | ESPE2021

Early-onset growth hormone treatment in Prader-Willi syndrome attenuates the risk of transition to severe obesity

Kodytkova Aneta , El Lababidi Eva , Čermakova Ivana , Černa Jana , Čižek Jindřich , Dvořakova Marcela , Kalvachova Božena , Magnova Olga , Neumann David , Novotna Dana , Obermannova Barbora , Plašilova Ivana , Pomahačova Renata , Průhova Štěpanka , Strnadel Jiři , Škvor Jaroslav , Šnajderova Marta , Šumnik Zdeněk , Zapletalova Jiřina , Kusalova Kateřina , Šilar Jiři , Kolouškova Stanislava , Zemkova Daniela , Lebl Jan ,

Background: Following a phase of feeding difficulties and underweight in early life, children with Prader-Willi syndrome (PWS) develop hyperphagia and a tendency towards severe obesity. Growth hormone therapy (GH) has been approved in PWS to compensate their growth failure but may exert also additional effects on muscle component and body composition as well.Objectives: We aimed to test if an early initiation of GH thera...

hrp0092fc5.6 | Thyroid | ESPE2019

Homozygous Loss-of-Function Mutation in the SLC26A7 Gene Coding a Novel Iodide Transporter Causes Goitrous Congenital Hypothyroidism

Suzuki Atsushi , Ishii Jun , Yoshida Aya , Yamguchi Naoya , Tanaka Tatsushi , Aoyama Kohei , Tateyama Michihiro , Chen I-Shan , Kubo Yoshihiro , Kimura Toru , Yazawa Takuya , Arimasu Yu , Kamma Hiroshi , Saitoh Shinji , Mizuno Haruo

Introduction: Iodide transport in the thyroid is crucial for thyroid hormone synthesis. A homozygous loss-of-function mutation in the SLC26A4gene coding an iodide transporter located at the apical side in the thyroid follicular cells causes Pendred syndrome accompanied with goitrous congenital hypothyroidism (CH) and sensorineural deafness. However, about half of patients with Pendred syndrome demonstrate normal thyroid function. This indicates anothe...